Որոնման արդյունքները - Barnes, Chris
- Ցուցադրվում են 1 - 20 արդյունքները 87
- Գնացեք Հաջորդ էջ
-
1
-
2
-
3
-
4
Dose Escalating and Bioavailability Phase 1 Studies Assessing Safety and Tolerability and Pharmacokinetics of Tildacerfont, a Small-Molecule CRF1 Receptor Antagonist Barnes, Chris, Offman, Elliot, Darago, Nora, Moriarty, David
Հրապարակվել է 2021Տեքստ -
5
-
6
-
7
-
8
-
9
Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data Harper, Paul, Favaloro, Emmanuel J., Curtin, Julie, Barnes, Chris, Dunkley, Scott
Հրապարակվել է 2016Տեքստ -
10
-
11
2364. Evaluation of Renal Function Changes in Patients With Prolonged Telavancin Therapy (>21 Days): Results From the Telavancin Observational Use Registry (TOUR™) Hassoun, Ali, Sundareshan, Vidya, Lacy, Melinda, Barnes, Chris, Castaneda-Ruiz, Bibiana
Հրապարակվել է 2018Տեքստ -
12
2369. Clinical Experience With Telavancin for Treatment of Patients With Monomicrobial S. aureus Infections (Vancomycin MIC ≥1 μg/mL) From TOUR™ Jacobs, Micah, Nwaigwe, Casmiar, Clay, Candice, Barnes, Chris, Castaneda-Ruiz, Bibiana
Հրապարակվել է 2018Տեքստ -
13
-
14
-
15
-
16
-
17
-
18
Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Rando... Siler, Thomas M., Moran, Edmund J., Barnes, Chris N., Crater, Glenn D.
Հրապարակվել է 2020Տեքստ -
19
-
20
Assessment of Steroid Hormones in Both Saliva and Blood During a Phase 2 Clinical Trial for the Use of Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia Keevil, Brian, Sarafoglou, Kyriakie, Moriarty, David, Huang, Michael, Barnes, Chris, Arlt, Wiebke
Հրապարակվել է 2021Տեքստ